Literature DB >> 7651750

Cultured skin fibroblasts derived from patients with mucolipidosis 4 are auto-fluorescent.

E Goldin1, E J Blanchette-Mackie, N K Dwyer, P G Pentchev, R O Brady.   

Abstract

Mucolipidosis 4 (ML4) is an autosomal recessive disorder with both lipid and mucopolysaccharide storage. The disease is characterized by severe visual impairment and psychomotor retardation. In our effort to find a phenotypic marker for ML4 fibroblasts, living cells were stained with fluorescent compounds. The staining pattern in cells was complicated by autofluorescence. A careful study revealed that auto-fluorescence by itself was a sufficient marker for viable ML4 fibroblasts. ML4 cells in cultures obtained from four unrelated patients contain auto-fluorescent material. Auto-fluorescence was noted over a wide range of excitation wavelengths from approximately 365 to approximately 546 nm. The most intense fluorescence was observed in the lower wave-length range. Cultured fibroblasts from normal individuals or obligate ML4 heterozygotes did not fluoresce under adequately controlled culture conditions. High passage number of inadequate feeding caused a small proportion of fibroblasts obtained from normal individuals to auto-fluoresce. The auto-fluorescent material co-localized with phase-dense inclusion bodies, shown to be lysosomes by staining with LAMP-ab. These findings imply that fluorescence may relate to the specific compound(s) stored in the lysosomes. In a comparative study, neuronal ceroid lipofuscinosis fibroblasts were also fluorescent. Fibroblasts from other diseases such as Gaucher disease and glycogenosis type 2 did not show any fluorescence. These findings are currently used in our functional cloning strategy for determining the gene involved in ML4.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651750     DOI: 10.1203/00006450-199506000-00003

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  18 in total

1.  The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel.

Authors:  Xian-Ping Dong; Xiping Cheng; Eric Mills; Markus Delling; Fudi Wang; Tino Kurz; Haoxing Xu
Journal:  Nature       Date:  2008-09-14       Impact factor: 49.962

2.  Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease.

Authors:  C S Chen; G Bach; R E Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 3.  Cation channel activity of mucolipin-1: the effect of calcium.

Authors:  Horacio F Cantiello; Nicolás Montalbetti; Wolfgang H Goldmann; Malay K Raychowdhury; Silvia González-Perrett; Gustavo A Timpanaro; Bernard Chasan
Journal:  Pflugers Arch       Date:  2005-08-23       Impact factor: 3.657

4.  Constitutive achlorhydria in mucolipidosis type IV.

Authors:  R Schiffmann; N K Dwyer; I A Lubensky; M Tsokos; V E Sutliff; J S Latimer; K P Frei; R O Brady; N W Barton; E J Blanchette-Mackie; E Goldin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

5.  Mucolipidosis IV consists of one complementation group.

Authors:  E Goldin; A Cooney; C R Kaneski; R O Brady; R Schiffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

6.  Macroautophagy is defective in mucolipin-1-deficient mouse neurons.

Authors:  Cyntia Curcio-Morelli; Florie A Charles; Matthew C Micsenyi; Yi Cao; Bhuvarahamurthy Venugopal; Marsha F Browning; Kostantin Dobrenis; Susan L Cotman; Steven U Walkley; Susan A Slaugenhaupt
Journal:  Neurobiol Dis       Date:  2010-06-28       Impact factor: 5.996

Review 7.  The role of TRPMLs in endolysosomal trafficking and function.

Authors:  Kartik Venkatachalam; Ching-On Wong; Michael X Zhu
Journal:  Cell Calcium       Date:  2014-10-28       Impact factor: 6.817

8.  Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells.

Authors:  Kartik Venkatachalam; A Ashleigh Long; Rebecca Elsaesser; Daria Nikolaeva; Kendal Broadie; Craig Montell
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

9.  Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.

Authors:  Bhuvarahamurthy Venugopal; Marsha F Browning; Cyntia Curcio-Morelli; Andrea Varro; Norman Michaud; Nanda Nanthakumar; Steven U Walkley; James Pickel; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

10.  Neuropathology of the Mcoln1(-/-) knockout mouse model of mucolipidosis type IV.

Authors:  Matthew C Micsenyi; Kostantin Dobrenis; Gloria Stephney; James Pickel; Marie T Vanier; Susan A Slaugenhaupt; Steven U Walkley
Journal:  J Neuropathol Exp Neurol       Date:  2009-02       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.